Exemption for SME research and proposal to remove obligations on best execution reporting

This chapter discusses the exemption from injection rules for SME research below a market cap of 200 million and the proposal to remove obligations in respect to best execution reporting. It explains how these exemptions work and discusses the broader context of Mifid II reforms and the capital markets framework review.